trihexyphenidyl has been researched along with Gangliosidoses in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Gangliosidoses: A group of autosomal recessive lysosomal storage disorders marked by the accumulation of GANGLIOSIDES. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the LYSOSOMES. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ushiyama, M | 1 |
| Hanyu, N | 1 |
| Ikeda, S | 1 |
| Yanagisawa, N | 1 |
1 other study available for trihexyphenidyl and Gangliosidoses
| Article | Year |
|---|---|
[A case of type III (adult) GM1-gangliosidosis that improved markedly with trihexyphenidyl].
Topics: Adult; Dystonia; Female; Gangliosidoses; Humans; Trihexyphenidyl | 1986 |